Paratek Pharmaceuticals Reports Third Quarter 2018 Financial Results
Paratek Pharmaceuticals, Inc. (PRTK)
Last paratek pharmaceuticals, inc. earnings: 2/25 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.paratekpharma.com
Company Research
Source: GlobeNewswire
--NUZYRA™ (omadacycline) approved by FDA for the treatment of CABP and ABSSSI -- -- SEYSARA™ (sarecycline) approved by FDA for the treatment of moderate to severe acne vulgaris -- -- Company planning for a February 2019 NUZYRA U.S. launch – BOSTON, Nov. 06, 2018 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics, today reported financial results and provided an update on financial, clinical, commercial and regulatory filing activities for the quarter ended September 30, 2018. “It has been an exciting and productive period for Paratek during which we achieved two significant milestones with the approval of NUZYRA and SEYSARA. NUZYRA was approved by the FDA as the first once-daily IV and oral antibiotic to treat both CABP and ABSSSI in nearly 20 years while the FDA approved SEYSARA for the treatment of inflammatory lesions of non-nodular moderate
Show less
Read more
Impact Snapshot
Event Time:
PRTK
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PRTK alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PRTK alerts
High impacting Paratek Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics